Overview / Abstract: |
Target Audience Activity Overview Learning Objectives Analyze recent efficacy and safety data of novel oral immunotherapy (OIT) agents that have the potential to substantially impact outcomes in patients with peanut allergies |
Expiration |
Mar 27, 2024 |
Discipline(s) |
Nursing CNE, Physician CME |
Format |
Online |
Credits / Hours |
0.5 |
Accreditation |
ACCME, ANCC, CBRN |
Presenters / Authors / Faculty |
Edwin H. Kim, MD MS |
Sponsors / Supporters / Grant Providers |
Physicians’ Education Resource®, LLC.; Aimmune Therapeutics, Inc. |
Keywords / Search Terms |
Relias LLC Allergy & Immunology, Pediatrics, Primary Care, Allergies, Anaphylaxis Free CE CME |